Essex Woodlands Healthcare Partners
EW Healthcare Partners is a growth equity firm focused exclusively on healthcare. The firm invests in fast-growing, revenue-generating healthcare companies (US$20M–$200M in revenues) and supports portfolio companies through capital, board participation, strategic guidance and its industry network. EW maintains active investments primarily in the United States and Europe.
Essex Woodlands Healthcare Partners
Palo Alto, California, United States, North America
Services
Growth equity investments
Provides capital to fast-growing, revenue-generating healthcare companies, typically with revenues of US$20M–$200M that are EBITDA-positive or near-positive. EW takes minority or majority positions.
Board participation and governance support
Board-level engagement with portfolio companies to provide strategic oversight and governance.
Strategic guidance and operational support
Provides strategic, operational and industry-specific expertise including regulatory, financing and R&D advice to accelerate value creation.
Network and commercial relationships
Access to EW’s industry network and sector relationships to support commercialization, partnerships and business development.
Limited partner reporting and fund-level reporting
Quarterly and annual reports for named funds available to Limited Partners; fund access requires credentials.
Growth equity investments
Provides capital to fast-growing, revenue-generating healthcare companies, typically with revenues of US$20M–$200M that are EBITDA-positive or near-positive. EW takes minority or majority positions.
Board participation and governance support
Board-level engagement with portfolio companies to provide strategic oversight and governance.
Strategic guidance and operational support
Provides strategic, operational and industry-specific expertise including regulatory, financing and R&D advice to accelerate value creation.
Network and commercial relationships
Access to EW’s industry network and sector relationships to support commercialization, partnerships and business development.
Limited partner reporting and fund-level reporting
Quarterly and annual reports for named funds available to Limited Partners; fund access requires credentials.
Portfolio
Partnered with EW to expand United States capacity and capabilities (news item on site).
#Gene-to-GMP development / advanced therapies
Earned rankings on Great Place to Work® and Fortune Best Workplaces in BioPharma (news item).
#Regenerative healing / cryopreserved human birth tissue products (ocular)
Described on site as an orthobiologics company focused on bone growth stimulation and joint pain therapy.
#Orthobiologics (bone growth stimulation and joint pain therapy)
EW acquired approximately a 25% minority stake in Boiron Développement (news item).
#Natural medicine / consumer healthcare
Listed on current portfolio page.
#Medical/healthcare technologies (listed under current portfolio)
Partnered with EW to expand United States capacity and capabilities (news item on site).
#Gene-to-GMP development / advanced therapies
Earned rankings on Great Place to Work® and Fortune Best Workplaces in BioPharma (news item).
#Regenerative healing / cryopreserved human birth tissue products (ocular)
Described on site as an orthobiologics company focused on bone growth stimulation and joint pain therapy.
#Orthobiologics (bone growth stimulation and joint pain therapy)
EW acquired approximately a 25% minority stake in Boiron Développement (news item).
#Natural medicine / consumer healthcare
Listed on current portfolio page.
#Medical/healthcare technologies (listed under current portfolio)